P. Massip

发表

A systematic review of computer-based patient record systems and quality of care: more randomized clinical trials or a broader approach?

C. Delpierre, L. Cuzin, J. Fillaux, 2004, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood.

É. Oksenhendler, B. Autran, P. Massip, 2004, Journal of Clinical Virology.

Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing

P. Massip, K. Sandres‐Saune, J. Izopet, 2011, AIDS.

Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses

L. Ferradini, P. Massip, C. Pasquier, 2010, Journal of acquired immune deficiency syndromes.

Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.

P. Massip, K. Sandres‐Saune, J. Izopet, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression

P. Massip, K. Sandres‐Saune, J. Izopet, 2010, AIDS.

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism

L. Cuzin, P. Massip, K. Sandres‐Saune, 2008, AIDS.

Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies

Christophe Pasquier, Michelle Cazabat, Jacques Izopet, 2007, Journal of Clinical Microbiology.

R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy

Christophe Pasquier, Michelle Cazabat, Jacques Izopet, 2005, Journal of acquired immune deficiency syndromes.

Local antibiotic prophylaxis in inguinal hernia repair.

P. Massip, F. Lazorthes, P. Chiotasso, 1992, Surgery, gynecology & obstetrics.

Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral Therapy

Jacques Izopet, Diane Descamps, F. Brun-Vézinet, 2001, Journal of Virology.

Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence.

P. Massip, J. Izopet, C. Loiseau, 2013, The Journal of antimicrobial chemotherapy.

Primary resistance of CCR 5-tropic HIV-1 to maraviroc cannot be predicted by the V 3 sequence

P. Massip, J. Izopet, C. Loiseau, 2013 .

Genotypic Prediction of HIV-1 CRF01-AE Tropism

P. Massip, C. Pasquier, K. Sandres‐Saune, 2012, Journal of Clinical Microbiology.

Genotypic prediction of HIV-1 subtype D tropism

P. Massip, K. Sandres‐Saune, J. Izopet, 2011, Retrovirology.

Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc.

M. Alvarez, P. Massip, J. Izopet, 2010, AIDS.

Decrease of Lewis frequency in HIV-infected patients: possible competition of fucosylated antigens with HIV for binding to DC-SIGN

P. Massip, C. Pasquier, J. Izopet, 2005, AIDS.

Infection, procréation et devenir

P. Massip, 2004 .

Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.

H. Fleury, P. Massip, J. Puel, 2000 .

Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease’s lymphadenitis

L. Cuzin, P. Massip, G. Martin-Blondel, 2016, Infection.

Disseminated Mycobacterium gordonae infection in a patient infected with human immunodeficiency virus.

P. Massip, L. Alric, R. Bauriaud, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

TST-Negative Individuals Do Not Lack Anti-Mycobacterial Responsiveness

P. Massip, M. Puissegur, B. Payre, 2008 .

Mycobacterial-immune reconstitution inflammatory syndrome: a cause of acute interstitial nephritis during HIV infection.

P. Massip, D. Chauveau, G. Martin-Blondel, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Giant cell arteritis and spinal cord compression: an overlap syndrome?

P. Massip, E. Uro-Coste, S. Le Guellec, 2006, Mayo Clinic proceedings.

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.

M. Alvarez, P. Massip, C. Pasquier, 2002, The Journal of infectious diseases.

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults

P. Massip, F. Raffi, F. Collin, 2009, AIDS.

Virological exploration of individuals with discordant HIV screening tests.

P. Massip, C. Pasquier, K. Sandres‐Saune, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis

M. Alvarez, P. Massip, P. Kyrtatos, 2013, Infection.

Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.

P. Brousset, John Calvin Reed, S. Krajewski, 1996, The American journal of pathology.

Impact de l'infection VIH sur l'infection palustre chez l'adulte

P. Massip, G. Martin-Blondel, B. Marchou, 2007 .

Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.

P. Massip, C. Pasquier, J. Izopet, 2012, The Journal of clinical investigation.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association wi

J. Ferrières, P. Massip, J. Tuech, 1999 .

In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection

H. Lassmann, P. Massip, R. Liblau, 2013, Neurology.

Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?

L. Cuzin, M. Alvarez, P. Massip, 2009, AIDS.

Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study

J. Ruidavets, C. Delpierre, P. Massip, 2013, BMC Infectious Diseases.

Panniculitis revealing qualitative alpha 1 antitrypsine deficiency (MS variant).

P. Massip, F. Loche, J. Bazex, 1999, European journal of dermatology : EJD.

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.

P. Massip, G. Laurent, M. Attal, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Necrotic panniculitis with α-1 antitrypsin deficiency

P. Massip, R. Viraben, C. Mathieu, 1986 .

Longitudinal study of body composition of 101 HIV men with lipodystrophy: dual-energy X-ray criteria for lipodystrophy evolution.

A. Sommet, C. Delpierre, P. Massip, 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Chronic Q Fever: Ninety-two Cases From France, Including 27 Cases Without Endocarditis

D. Raoult, M. Drancourt, P. Brouqui, 1993 .

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.

A. Sommet, C. Delpierre, P. Massip, 2005, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Pfcrt K76T mutation and its associations in imported Plasmodium falciparum malaria cases.

P. Massip, B. Marchou, R. Fabre, 2004, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Chronic Q Fever: Diagnosis and Follow‐Up

D. Raoult, P. Massip, J. Harlé, 1990, Annals of the New York Academy of Sciences.

Treatment Intensification with Abacavir in HIV-Infected Patients with at Least 12 Weeks Previous Lamivudine/Zidovudine Treatment

C. Katlama, W. Rozenbaum, P. Massip, 2000, Antiviral therapy.

Antiviral Effect of Maraviroc in Semen: A Case Report

P. Massip, C. Pasquier, J. Izopet, 2012, Antiviral therapy.

CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals

P. Massip, J. Izopet, C. Loiseau, 2016, Mucosal Immunology.

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

P. Massip, C. Leport, P. Lutun, 1989, Antimicrobial Agents and Chemotherapy.

Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing.

P. Massip, J. Izopet, S. Raymond, 2013, The Journal of antimicrobial chemotherapy.

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy

P. Massip, B. Perret, J. Fauvel, 2007, Clinical chemistry and laboratory medicine.

Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.

C. Delpierre, P. Massip, F. Marion-Latard, 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Decreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatment.

P. Massip, C. Pasquier, L. Bujan, 2006, Journal of andrology.

Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes

A. Berrebi, P. Massip, C. Pasquier, 2004, AIDS.

A dose‐ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment‐naive subjects

T. Harrer, C. Katlama, S. Staszewski, 1998, AIDS.

Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV.

P. Massip, R. Liblau, A. Blancher, 2011, Brain : a journal of neurology.

Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature

L. Cuzin, J. Fillaux, M. Alvarez, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus.

P. Brousset, P. Massip, G. Delsol, 1996, Human pathology.

Disseminated osteomyelitis or bone metastases of breast cancer: 18F-FDG-PET/CT helps unravel an unusual presentation

M. Alvarez, P. Massip, B. Marchou, 2014, Annals of Nuclear Medicine.

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

P. Massip, J. Izopet, S. Raymond, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Epstein‐Barr virus (EBV) replicative gene expression in tumour cells of AIDS‐related non‐Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV

P. Brousset, P. Massip, G. Delsol, 1994, AIDS.

Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV.

A. Berrebi, P. Massip, C. Pasquier, 2003, Journal of medical virology.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Decrease of mitochondrial DNA level in sperm from patients infected with human immunodeficiency virus-1 linked to nucleoside analogue reverse transcriptase inhibitors.

L. Cuzin, P. Massip, C. Pasquier, 2010, Fertility and sterility.

Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.

P. Massip, N. Sans, B. Marchou, 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Cefotaxime in the treatment of septicaemia and endocarditis.

J. Ragnaud, P. Massip, J. Aubertin, 1980, The Journal of antimicrobial chemotherapy.

[Systemic manifestations of hemorrhagic rectocolitis: apropos of a case of hemorrhagic rectocolitis associated with multiple sclerosis].

P. Massip, L. Alric, M. Laroche, 1997, La Revue de medecine interne.

Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit.

P. Massip, L. Molinier, A. Berry, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[Penicilliosis in Vietnam: a series of 94 patients].

P. Massip, M. Strobel, Y. Buisson, 2010, La Revue de medecine interne.

Successful Treatment with Nitazoxanide of Enterocytozoon bieneusi Microsporidiosis in a Patient with AIDS

P. Massip, A. Datry, A. Bicart-Sée, 2000, Antimicrobial Agents and Chemotherapy.

Automated Extraction and Quantification of Human Cytomegalovirus DNA in Whole Blood by Real-Time PCR Assay

P. Massip, C. Mengelle, C. Pasquier, 2003, Journal of Clinical Microbiology.

Blood by Real-Time PCR Assay Human Cytomegalovirus DNA in Whole Automated Extraction and Quantification of

P. Massip, C. Mengelle, C. Pasquier, 2003 .

Performance Testing of PCR Assay in Blood Samples for the Diagnosis of Toxoplasmic Encephalitis in AIDS Patients from the French Departments of America and Genetic Diversity of Toxoplasma gondii: A Prospective and Multicentric Study

P. Preux, M. Dupon, P. Massip, 2016, PLoS neglected tropical diseases.

Spondylodiscitis due to Aerococcus urinae: A First Report

P. Massip, L. Astudillo, L. Sailler, 2003, Scandinavian journal of infectious diseases.

Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children

A. Berrebi, P. Massip, C. Pasquier, 2000, AIDS.

Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients

P. Massip, I. Tack, E. Chatelut, 2009, AIDS.

Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.

P. Massip, J. Izopet, M. Segondy, 1999, Journal of acquired immune deficiency syndromes.

Assessment of a standardized reverse-transcriptase PCR assay for quantifying HIV-1 RNA in plasma and serum.

P. Massip, J. Puel, J. Izopet, 1996, Journal of virological methods.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Naïve T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy

R. Cheynier, F. Barré-Sinoussi, M. Nugeyre, 2006, Journal of Virology.

Naı̈ve T-Cell Depletion Related to Infection by X 4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy †

R. Cheynier, F. Barré-Sinoussi, M. Nugeyre, 2006 .

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine

P. Massip, C. Pasquier, J. Puel, 1999, Journal of medical virology.

Factors associated with a strictly undetectable viral load in HIV‐1‐infected patients

L. Cuzin, P. Massip, J. Izopet, 2012, HIV medicine.

Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM)

L. Cuzin, P. Massip, G. Martin-Blondel, 2017, Sexually Transmitted Infections.

Lipodystrophia with protease inhibitors in HIV patients.

J. Montastruc, L. Cuzin, P. Massip, 1997, Therapie.

Correlates of late HIV diagnosis: implications for testing policy

F. Lert, C. Delpierre, L. Cuzin, 2007, International journal of STD & AIDS.

Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients.

P. Brousset, E. Cesarman, P. Massip, 2001, Human pathology.

Comparison of the effect of semen from HIV-infected and uninfected men on CD4+ T-cell infection

C. Pineau, P. Massip, O. Zirafi, 2016, AIDS.

Outbreak of trichinellosis in the Midi-Pyrénées region of France January - March 1998.

V. Vaillant, J. Desenclos, P. Massip, 1998, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Peripheral intramonocytic leishmanias in an AIDS patient

P. Massip, P. Laharrague, G. Fillola, 1992, Journal of clinical microbiology.

[Chronic headaches].

P. Massip, F. Bonneville, D. Brassat, 2011, La Revue de medecine interne.

Streptococcus milleri Group Infection Associated with Digestive Fistula in Patients with Vascular Graft: Report of Seven Cases and Review

P. Massip, B. Marchou, E. Bonnet, 2007, Infection.

Frozen shoulder: a new delayed complication of protease inhibitor therapy? .

P. Massip, C. Dromer, V. Andrieu, 1998, Revue du rhumatisme.

FOXP3 mRNA Levels are Decreased in Peripheral Blood CD4+ Lymphocytes From HIV-Positive Patients

P. Massip, A. Blancher, B. Puissant, 2005, Journal of acquired immune deficiency syndromes.

Antithrombin III: Substitutive Treatment of the Hereditary Deficiency

P. Massip, P. Laharrague, A. Cérène, 1980, Thrombosis and Haemostasis.

HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy

P. Massip, C. Pasquier, J. Izopet, 2009, PloS one.

[Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients].

P. Brousset, P. Massip, B. Marchou, 1997, La Revue de medecine interne.

Long‐term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs

P. Massip, F. Raffi, F. Collin, 2007, HIV medicine.

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.

H. Fleury, P. Massip, J. Puel, 1999, AIDS.

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.

C. Delpierre, L. Cuzin, P. Massip, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Q fever endocarditis in the south of France.

D. Raoult, P. Massip, J. Etienne, 1987, The Journal of infectious diseases.

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations

P. Massip, C. Pasquier, J. Puel, 1999, Journal of medical virology.

Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.

P. Massip, C. Pasquier, J. Izopet, 2006, AIDS research and human retroviruses.

High Frequency of Pneumocystis carinii sp.f. hominis Colonization in HIV‐Negative Patients

P. Massip, E. Dei‐Cas, C. Raccurt, 1997, The Journal of eukaryotic microbiology.

bcl‐2 proto‐oncogene and Epstein–Barr virus latent membrane protein‐1 expression in AIDS‐related lymphoma

P. Brousset, P. Massip, G. Delsol, 1994, Histopathology.

Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.

P. Massip, C. Pasquier, J. Izopet, 2014, Journal of Antimicrobial Chemotherapy.

[Kikuchi syndrome, Hashimoto thyroiditis and lupus serology. Apropos of a case].

P. Brousset, P. Massip, M. Tubery, 1996, La Revue de medecine interne.

[In vitro activity of twenty antibiotics against Rhodococcus equi].

P. Massip, N. Moatti, M. Archambaud, 1991, Pathologie-biologie.

Utilisation and Safety of Low Molecular Weight Heparins

M. Lapeyre-Mestre, J. Montastruc, P. Massip, 2003, Drug safety.

Impact du paludisme sur l’infection par le VIH

L. Cuzin, P. Massip, G. Martin-Blondel, 2010 .

Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals

M. Lapeyre-Mestre, J. Montastruc, P. Massip, 2004, European Journal of Clinical Pharmacology.

Intermittent human immunodeficiency type 1 virus (HIV-1) shedding in semen and efficiency of sperm processing despite high seminal HIV-1 RNA levels.

M. Alvarez, P. Massip, C. Pasquier, 2002, Fertility and sterility.

Low-Rate Emergence of Thymidine Analogue Mutations and Multi-Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Gene in Therapy-Naive Patients Receiving Stavudine plus Lamivudine Combination Therapy

M. Mouroux, V. Calvez, F. Brun-Vézinet, 2000, Antiviral therapy.

Impact of protease inhibitors on AIDS‐defining events and hospitalizations in 10 French AIDS reference centres

P. Massip, J. Lang, P. Dellamonica, 1997, AIDS.

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV‐1 infection

P. Massip, C. Pasquier, J. Puel, 2000, Journal of medical virology.

[Anti-retroviral treatment interruptions in HIV-infected adults: causes, clinical, immunological and virological consequences].

A. Sommet, C. Delpierre, L. Cuzin, 2003, La Revue de medecine interne.

HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count

P. Massip, C. Pasquier, J. Izopet, 2004, Journal of medical virology.

Effects of Discontinuing Stavudine or Protease Inhibitor Therapy on Human Immunodeficiency Virus—Related Fat Redistribution Evaluated by Dual‐Energy X‐Ray Absorptiometry

A. Sommet, J. Montastruc, C. Delpierre, 2006, Pharmacotherapy.

An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients

J. Ruidavets, J. Ferrières, P. Massip, 2001, AIDS.

Reversible nucleoside analogue-associated lactic acidosis despite a prolonged course

M. Obadia, M. Alvarez, P. Massip, 2003, Intensive Care Medicine.

Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV‐1 resistance genotype

P. Massip, C. Pasquier, J. Puel, 2002, Journal of medical virology.

Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure

Florence Nicot, Jacques Izopet, Jean-Pierre Aboulker, 2011, PloS one.

Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.

P. Massip, C. Pasquier, J. Puel, 2002, Virology.

Predictive factors of treatment interruption duration in a cohort of HIV-1 infected patients with CD4 count greater than 350 cells per mm3.

C. Delpierre, L. Cuzin, J. Fillaux, 2006, Medecine et maladies infectieuses.

Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism

P. Massip, C. Pasquier, J. Izopet, 2009, Journal of Clinical Microbiology.

Quantification of HIV‐1 proviral DNA by a standardized colorimetric PCR‐based assay

P. Massip, C. Pasquier, J. Puel, 1998, Journal of medical virology.

[Shortened antibiotic therapy of meningococcal meningitis: 5-day administration of ceftriaxone].

P. Massip, B. Marchou, J. Auvergnat, 1988, Pathologie-biologie.

Blood Transaminase Elevation with Pegylated Interferon Alfa 2b Plus Ribavirin in an HIV/HCV Coinfected Haemophilic Patient

J. Montastruc, P. Massip, S. Claeyssens, 2006, Infection.

Neurotoxicity of artemisinin: possible counseling and treatment of side effects.

P. Massip, B. Marchou, E. Bonnet, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].

P. Massip, M. Attal, H. Rubié, 1988, Pathologie-biologie.

Toxoplasmosis in two renal transplant recipients: diagnosis by bone marrow aspiration.

P. Massip, L. Rostaing, D. Durand, 1995, Transplantation proceedings.

Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART

P. Massip, C. Pasquier, J. Izopet, 2005, AIDS.

[Direct diagnosis of Chlamydia trachomatis genital infections: culture or PCR?].

P. Massip, G. Chabanon, P. Bennet, 1998, Pathologie-biologie.

[Experience of an adherence support for HIV-1 seropositive patients with failure under treatment].

C. Delpierre, L. Cuzin, P. Massip, 2003, La Revue de medecine interne.

Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients.

J. Ruidavets, P. Massip, B. Perret, 2008, AIDS research and human retroviruses.

Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.

G. Salama, P. Massip, C. Pasquier, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[Cerebral lesions in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions].

C. Manelfe, I. Berry, P. Massip, 1995, Journal of neuroradiology. Journal de neuroradiologie.

Triple nucleoside reverse transcriptase inhibitor‐ vs. nonnucleoside reverse transcriptase inhibitor‐containing regimens as first‐line therapy: efficacy and durability in a prospective cohort of French HIV‐infected patients

C. Delpierre, L. Cuzin, P. Massip, 2005, HIV medicine.

Exceptional Cases More may be less : increasing extracorporeal blood flow in an axillary arterio-arterial access decreases effective clearance

P. Massip, D. Chauveau, G. Martin-Blondel, 2011 .

Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral Therapy

P. Massip, J. Izopet, F. Mammano, 2001, Journal of virology.

Low-dose splenic irradiation in human immunodeficiency virus-related immune thrombocytopenia.

P. Massip, P. Giraud, J. Auvergnat, 1996, International journal of radiation oncology, biology, physics.

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

P. Massip, C. Pasquier, J. Puel, 2000, AIDS.

[Evaluation of clinical practice: audit of prophylactic antibiotics in urology].

P. Massip, J. Rozé, B. Malavaud, 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Severe knee arthritis due to Eikenella corrodens following a human bite.

P. Massip, L. Alric, E. Bonnet, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.